Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, partially blind, placebo controlled, crossover, single oral dose study to assess the effect of concomitant antacid (calcium carbonate / magnesium hydroxide) on the pharmacokinetics and pharmacodynamics of SMC021 (0.8 mg Salmon calcitonin/200 mg 5-CNAC) in healthy postmenopausal women

Next Previous
X
Search
Trial Profile

A randomized, partially blind, placebo controlled, crossover, single oral dose study to assess the effect of concomitant antacid (calcium carbonate / magnesium hydroxide) on the pharmacokinetics and pharmacodynamics of SMC021 (0.8 mg Salmon calcitonin/200 mg 5-CNAC) in healthy postmenopausal women

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2012

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Calcitonin (Primary) ; Calcium carbonate; Magnesium hydroxide
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Novartis

    • Most Recent Events

    • 21 Jun 2007 Status change from in progress to completed
    • 30 Jan 2007 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top